APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Swine Vaccines

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Selected research

Industry Growth & Trends

Global Swine Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174039050126 December 2025111 pages

Choose your research edition.

Industry ResearchSwine Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Vaccines Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Vaccines Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Vaccines Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.

Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.

Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.

Read the full market overview

China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.

Report Scope

This report provides a structured, data-driven view of the global Swine Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Swine Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Swine Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Swine Vaccines Market by Company

Merck

Boehringer Ingelheim

Jinyu Bio-Technology

CAHIC

Tecon

Zoetis

Ceva

Hile Bio

Chopper Biology

WINSUN

Hipra

Ringpu Biology

ChengDu Tecbond

DHN

CAVAC

Virbac

HVRI

Bioveta

Swine Vaccines Segment by Type

CSF Vaccines

FMD Vaccines

Porcine Circovirus Vaccines

PRRS Vaccines

Others

Swine Vaccines Segment by Application

Government Tender

Market Sales

Swine Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CSF Vaccines Table 2. Major Company of FMD Vaccines Table 3. Major Company of Porcine Circovirus Vaccines Table 4. Major Company of PRRS Vaccines Table 5. Major Company of Others Table 6. Global Swine Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 8. Global Swine Vaccines Sales Market Share in Volume by Type (2021-2026) Table 9. Global Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 10. Global Swine Vaccines Sales Market Share in Value by Type (2021-2026) Table 11. Global Swine Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 12. Global Swine Vaccines Sales by Type (2027-2032) & (M Doses) Table 13. Global Swine Vaccines Sales Market Share in Volume by Type (2027-2032) Table 14. Global Swine Vaccines Sales by Type (2027-2032) & (US$ Million) Table 15. Global Swine Vaccines Sales Market Share in Value by Type (2027-2032) Table 16. Global Swine Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 17. North America Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 18. North America Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Europe Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 22. Asia-Pacific Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 24. Latin America Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Swine Vaccines Sales by Type (2021-2026) & (M Doses) Table 26. Middle East and Africa Swine Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Swine Vaccines Industry Trends Table 28. Swine Vaccines Industry Drivers Table 29. Swine Vaccines Industry Opportunities and Challenges Table 30. Swine Vaccines Industry Restraints Table 31. Global Swine Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Swine Vaccines Revenue Market Share by Company (2021-2026) Table 33. Global Swine Vaccines Sales by Company (2021-2026) & (M Doses) Table 34. Global Swine Vaccines Sales Share by Company (2021-2026) Table 35. Global Swine Vaccines Market Price by Company (2021-2026) & (USD/K Doses) Table 36. Global Swine Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Swine Vaccines Major Company Production Sites and Headquarters Table 38. Global Swine Vaccines Company, Product Type & Application Table 39. Global Swine Vaccines Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Swine Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Swine Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Swine Vaccines Sales by Region (2021-2026) & (M Doses) Table 44. Global Swine Vaccines Sales Market Share in Volume by Region (2021-2026) Table 45. Global Swine Vaccines Sales by Region (2021-2026) & (US$ Million) Table 46. Global Swine Vaccines Sales Market Share in Value by Region (2021-2026) Table 47. Global Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 48. Global Swine Vaccines Sales by Region (2027-2032) & (M Doses) Table 49. Global Swine Vaccines Sales Market Share in Volume by Region (2027-2032) Table 50. Global Swine Vaccines Sales by Region (2027-2032) & (US$ Million) Table 51. Global Swine Vaccines Sales Market Share in Value by Region (2027-2032) Table 52. Global Swine Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 53. Global Swine Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 55. Global Swine Vaccines Sales Market Share in Volume by Application (2021-2026) Table 56. Global Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 57. Global Swine Vaccines Sales Market Share in Value by Application (2021-2026) Table 58. Global Swine Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 59. Global Swine Vaccines Sales by Application (2027-2032) & (M Doses) Table 60. Global Swine Vaccines Sales Market Share in Volume by Application (2027-2032) Table 61. Global Swine Vaccines Sales by Application (2027-2032) & (US$ Million) Table 62. Global Swine Vaccines Sales Market Share in Value by Application (2027-2032) Table 63. Global Swine Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 64. North America Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 65. North America Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 67. Europe Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 69. Asia-Pacific Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 71. Latin America Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Swine Vaccines Sales by Application (2021-2026) & (M Doses) Table 73. Middle East and Africa Swine Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 77. Merck Swine Vaccines Product Portfolio Table 78. Merck Recent Development Table 79. Boehringer Ingelheim Company Information Table 80. Boehringer Ingelheim Business Overview Table 81. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 82. Boehringer Ingelheim Swine Vaccines Product Portfolio Table 83. Boehringer Ingelheim Recent Development Table 84. Jinyu Bio-Technology Company Information Table 85. Jinyu Bio-Technology Business Overview Table 86. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 87. Jinyu Bio-Technology Swine Vaccines Product Portfolio Table 88. Jinyu Bio-Technology Recent Development Table 89. CAHIC Company Information Table 90. CAHIC Business Overview Table 91. CAHIC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 92. CAHIC Swine Vaccines Product Portfolio Table 93. CAHIC Recent Development Table 94. Tecon Company Information Table 95. Tecon Business Overview Table 96. Tecon Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 97. Tecon Swine Vaccines Product Portfolio Table 98. Tecon Recent Development Table 99. Zoetis Company Information Table 100. Zoetis Business Overview Table 101. Zoetis Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 102. Zoetis Swine Vaccines Product Portfolio Table 103. Zoetis Recent Development Table 104. Ceva Company Information Table 105. Ceva Business Overview Table 106. Ceva Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 107. Ceva Swine Vaccines Product Portfolio Table 108. Ceva Recent Development Table 109. Hile Bio Company Information Table 110. Hile Bio Business Overview Table 111. Hile Bio Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 112. Hile Bio Swine Vaccines Product Portfolio Table 113. Hile Bio Recent Development Table 114. Chopper Biology Company Information Table 115. Chopper Biology Business Overview Table 116. Chopper Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 117. Chopper Biology Swine Vaccines Product Portfolio Table 118. Chopper Biology Recent Development Table 119. WINSUN Company Information Table 120. WINSUN Business Overview Table 121. WINSUN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 122. WINSUN Swine Vaccines Product Portfolio Table 123. WINSUN Recent Development Table 124. Hipra Company Information Table 125. Hipra Business Overview Table 126. Hipra Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 127. Hipra Swine Vaccines Product Portfolio Table 128. Hipra Recent Development Table 129. Ringpu Biology Company Information Table 130. Ringpu Biology Business Overview Table 131. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 132. Ringpu Biology Swine Vaccines Product Portfolio Table 133. Ringpu Biology Recent Development Table 134. ChengDu Tecbond Company Information Table 135. ChengDu Tecbond Business Overview Table 136. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 137. ChengDu Tecbond Swine Vaccines Product Portfolio Table 138. ChengDu Tecbond Recent Development Table 139. DHN Company Information Table 140. DHN Business Overview Table 141. DHN Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 142. DHN Swine Vaccines Product Portfolio Table 143. DHN Recent Development Table 144. CAVAC Company Information Table 145. CAVAC Business Overview Table 146. CAVAC Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 147. CAVAC Swine Vaccines Product Portfolio Table 148. CAVAC Recent Development Table 149. Virbac Company Information Table 150. Virbac Business Overview Table 151. Virbac Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 152. Virbac Swine Vaccines Product Portfolio Table 153. Virbac Recent Development Table 154. HVRI Company Information Table 155. HVRI Business Overview Table 156. HVRI Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 157. HVRI Swine Vaccines Product Portfolio Table 158. HVRI Recent Development Table 159. Bioveta Company Information Table 160. Bioveta Business Overview Table 161. Bioveta Swine Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 162. Bioveta Swine Vaccines Product Portfolio Table 163. Bioveta Recent Development Table 164. North America Swine Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 165. North America Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 166. North America Swine Vaccines Sales Market Share by Country (2021-2026) Table 167. North America Swine Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 168. North America Swine Vaccines Sales Market Share Forecast by Country (2027-2032) Table 169. North America Swine Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. North America Swine Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 171. North America Swine Vaccines Market Share by Country (2021-2026) Table 172. North America Swine Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. North America Swine Vaccines Market Share Forecast by Country (2027-2032) Table 174. Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 175. Europe Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 176. Europe Swine Vaccines Sales Market Share by Country (2021-2026) Table 177. Europe Swine Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 178. Europe Swine Vaccines Sales Market Share Forecast by Country (2027-2032) Table 179. Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Europe Swine Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 181. Europe Swine Vaccines Market Share by Country (2021-2026) Table 182. Europe Swine Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Europe Swine Vaccines Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 186. Asia-Pacific Swine Vaccines Sales Market Share by Country (2021-2026) Table 187. Asia-Pacific Swine Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 188. Asia-Pacific Swine Vaccines Sales Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Swine Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 191. Asia-Pacific Swine Vaccines Market Share by Country (2021-2026) Table 192. Asia-Pacific Swine Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Asia-Pacific Swine Vaccines Market Share Forecast by Country (2027-2032) Table 194. Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 195. Latin America Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 196. Latin America Swine Vaccines Sales Market Share by Country (2021-2026) Table 197. Latin America Swine Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 198. Latin America Swine Vaccines Sales Market Share Forecast by Country (2027-2032) Table 199. Latin America Swine Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Latin America Swine Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 201. Latin America Swine Vaccines Market Share by Country (2021-2026) Table 202. Latin America Swine Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Latin America Swine Vaccines Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Swine Vaccines Sales by Country (2021-2026) & (M Doses) Table 206. Middle East and Africa Swine Vaccines Sales Market Share by Country (2021-2026) Table 207. Middle East and Africa Swine Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 208. Middle East and Africa Swine Vaccines Sales Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Swine Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 211. Middle East and Africa Swine Vaccines Market Share by Country (2021-2026) Table 212. Middle East and Africa Swine Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Middle East and Africa Swine Vaccines Market Share Forecast by Country (2027-2032) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Swine Vaccines Distributors List Table 217. Swine Vaccines Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Swine Vaccines Image Figure 2. Global Swine Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Vaccines Sales (2021-2032) & (M Doses) Figure 5. CSF Vaccines Image Figure 6. Global CSF Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. FMD Vaccines Image Figure 8. Global FMD Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Porcine Circovirus Vaccines Image Figure 10. Global Porcine Circovirus Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 11. PRRS Vaccines Image Figure 12. Global PRRS Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (M Doses) Figure 15. Global Swine Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Swine Vaccines Market Share by Type 2025 VS 2032 Figure 17. North America Swine Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. North America Swine Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Europe Swine Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Europe Swine Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Swine Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Latin America Swine Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Swine Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Swine Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Swine Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Government Tender Image Figure 30. Global Government Tender Sales YoY Growth (2021-2032) & (M Doses) Figure 31. Market Sales Image Figure 32. Global Market Sales Sales YoY Growth (2021-2032) & (M Doses) Figure 33. Global Swine Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Swine Vaccines Market Share by Application 2025 VS 2032 Figure 35. North America Swine Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. North America Swine Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Europe Swine Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Europe Swine Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Swine Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Swine Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Latin America Swine Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Swine Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Swine Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Swine Vaccines Sales Market Share in Value by Application in 2025 Figure 45. North America Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. North America Swine Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Swine Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Europe Swine Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Swine Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Asia-Pacific Swine Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Swine Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Latin America Swine Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Swine Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Swine Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 62. Middle East and Africa Swine Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Swine Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Swine Vaccines Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Swine Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • CSF Vaccines
  • FMD Vaccines
  • Porcine Circovirus Vaccines
  • PRRS Vaccines
  • Others
Applications
  • Government Tender
  • Market Sales
Companies covered
  • Merck
  • Boehringer Ingelheim
  • Jinyu Bio-Technology
  • CAHIC
  • Tecon
  • Zoetis
  • Ceva
  • Hile Bio
  • Chopper Biology
  • WINSUN
  • Hipra
  • Ringpu Biology
  • ChengDu Tecbond
  • DHN
  • CAVAC
  • Virbac
  • HVRI
  • Bioveta

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Swine Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Swine Vaccines Market by Type
  6. 1.3.1 CSF Vaccines
  7. 1.3.2 FMD Vaccines
  8. 1.3.3 Porcine Circovirus Vaccines
  9. 1.3.4 PRRS Vaccines
  10. 1.3.5 Others
  11. 1.4 Global Swine Vaccines Market Size by Type
  12. 1.4.1 Global Swine Vaccines Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Swine Vaccines Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Swine Vaccines Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Swine Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Swine Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Swine Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Swine Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Swine Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Swine Vaccines Industry Trends
  2. 2.2 Swine Vaccines Industry Drivers
  3. 2.3 Swine Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Swine Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Swine Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Swine Vaccines Price (2021-2026)
  4. 3.4 Global Swine Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Swine Vaccines Company, Product Type & Application
  7. 3.7 Global Swine Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Vaccines Tier 1, Tier 2, and Tier 3
4 Swine Vaccines Regional Status and Outlook
  1. 4.1 Global Swine Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Swine Vaccines Historic Market Size by Region
  3. 4.2.1 Global Swine Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Swine Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Swine Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Swine Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Swine Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Swine Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Vaccines by Application
  1. 5.1 Swine Vaccines Market by Application
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Swine Vaccines Market Size by Application
  5. 5.2.1 Global Swine Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Swine Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Swine Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Swine Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Swine Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Swine Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Swine Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Swine Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Swine Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Jinyu Bio-Technology
  14. 6.3.1 Jinyu Bio-Technology Company Information
  15. 6.3.2 Jinyu Bio-Technology Business Overview
  16. 6.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
  18. 6.3.5 Jinyu Bio-Technology Recent Developments
  19. 6.4 CAHIC
  20. 6.4.1 CAHIC Company Information
  21. 6.4.2 CAHIC Business Overview
  22. 6.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 CAHIC Swine Vaccines Product Portfolio
  24. 6.4.5 CAHIC Recent Developments
  25. 6.5 Tecon
  26. 6.5.1 Tecon Company Information
  27. 6.5.2 Tecon Business Overview
  28. 6.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tecon Swine Vaccines Product Portfolio
  30. 6.5.5 Tecon Recent Developments
  31. 6.6 Zoetis
  32. 6.6.1 Zoetis Company Information
  33. 6.6.2 Zoetis Business Overview
  34. 6.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zoetis Swine Vaccines Product Portfolio
  36. 6.6.5 Zoetis Recent Developments
  37. 6.7 Ceva
  38. 6.7.1 Ceva Company Information
  39. 6.7.2 Ceva Business Overview
  40. 6.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ceva Swine Vaccines Product Portfolio
  42. 6.7.5 Ceva Recent Developments
  43. 6.8 Hile Bio
  44. 6.8.1 Hile Bio Company Information
  45. 6.8.2 Hile Bio Business Overview
  46. 6.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hile Bio Swine Vaccines Product Portfolio
  48. 6.8.5 Hile Bio Recent Developments
  49. 6.9 Chopper Biology
  50. 6.9.1 Chopper Biology Company Information
  51. 6.9.2 Chopper Biology Business Overview
  52. 6.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chopper Biology Swine Vaccines Product Portfolio
  54. 6.9.5 Chopper Biology Recent Developments
  55. 6.10 WINSUN
  56. 6.10.1 WINSUN Company Information
  57. 6.10.2 WINSUN Business Overview
  58. 6.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 WINSUN Swine Vaccines Product Portfolio
  60. 6.10.5 WINSUN Recent Developments
  61. 6.11 Hipra
  62. 6.11.1 Hipra Company Information
  63. 6.11.2 Hipra Business Overview
  64. 6.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hipra Swine Vaccines Product Portfolio
  66. 6.11.5 Hipra Recent Developments
  67. 6.12 Ringpu Biology
  68. 6.12.1 Ringpu Biology Company Information
  69. 6.12.2 Ringpu Biology Business Overview
  70. 6.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ringpu Biology Swine Vaccines Product Portfolio
  72. 6.12.5 Ringpu Biology Recent Developments
  73. 6.13 ChengDu Tecbond
  74. 6.13.1 ChengDu Tecbond Company Information
  75. 6.13.2 ChengDu Tecbond Business Overview
  76. 6.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
  78. 6.13.5 ChengDu Tecbond Recent Developments
  79. 6.14 DHN
  80. 6.14.1 DHN Company Information
  81. 6.14.2 DHN Business Overview
  82. 6.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 DHN Swine Vaccines Product Portfolio
  84. 6.14.5 DHN Recent Developments
  85. 6.15 CAVAC
  86. 6.15.1 CAVAC Company Information
  87. 6.15.2 CAVAC Business Overview
  88. 6.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CAVAC Swine Vaccines Product Portfolio
  90. 6.15.5 CAVAC Recent Developments
  91. 6.16 Virbac
  92. 6.16.1 Virbac Company Information
  93. 6.16.2 Virbac Business Overview
  94. 6.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Virbac Swine Vaccines Product Portfolio
  96. 6.16.5 Virbac Recent Developments
  97. 6.17 HVRI
  98. 6.17.1 HVRI Company Information
  99. 6.17.2 HVRI Business Overview
  100. 6.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 HVRI Swine Vaccines Product Portfolio
  102. 6.17.5 HVRI Recent Developments
  103. 6.18 Bioveta
  104. 6.18.1 Bioveta Company Information
  105. 6.18.2 Bioveta Business Overview
  106. 6.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Bioveta Swine Vaccines Product Portfolio
  108. 6.18.5 Bioveta Recent Developments
7 North America by Country
  1. 7.1 North America Swine Vaccines Sales by Country
  2. 7.1.1 North America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Swine Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Swine Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Swine Vaccines Market Size by Country
  6. 7.2.1 North America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Swine Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Swine Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Swine Vaccines Sales by Country
  2. 8.1.1 Europe Swine Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Swine Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Swine Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Swine Vaccines Market Size by Country
  6. 8.2.1 Europe Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Swine Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Swine Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Swine Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Swine Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Swine Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Swine Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Swine Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Swine Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Swine Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Swine Vaccines Sales by Country
  2. 10.1.1 South America Swine Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Swine Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Swine Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Swine Vaccines Market Size by Country
  6. 10.2.1 South America Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Swine Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Swine Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Swine Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Swine Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Swine Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Swine Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Swine Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Swine Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Swine Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Swine Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Swine Vaccines Value Chain Analysis
  2. 12.1.1 Swine Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Swine Vaccines Production Mode & Process
  7. 12.2 Swine Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Swine Vaccines Distributors
  10. 12.2.3 Swine Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst